Advertisement

Echothiophate Powder for Ophthalmic Solution

[06 March 2013]

Products Affected - Description

Phospholine Iodide 0.125%, Pfizer
5 mL bottle (NDC 00046-1065-05)

Reason for the Shortage

Pfizer (formerly Wyeth) states Phospholine Iodide is in short supply due to a raw material shortage.

Available Products

No presentations are readily available.

Estimated Resupply Dates

  • Pfizer (formerly Wyeth) is the only manufacturer of echothiophate powder for ophthalmic solution (Phospholine Iodide).
  • Pfizer (formerly Wyeth) has product available through a limited distribution plan to physicians and pharmacists. Details for ordering can be obtained through Pfizer at 1-800-666-7248.

Related Shortages

Updated

March 6, 2013; December 14, 2012; September 19, 2012; June 29, 2012; March 30, 2012; January 27, 2012; November 15, 2011; September 27, 2011; August 5, 2011; July 18, 2011; May 9, 2011; March 8, 2011; January 26, 2011; December 2, 2010; October 26, 2010; August 18, 2010; June 22, 2010; April 27, 2010; February 26, 2010; January 20, 2010; November 11, 2009; September 22, 2009; July 31, 2009; May 4, 2009; March 4, 2009; January 29, 2009; January 9, 2009; December 15, 2008; August 8, 2008; July, 21, 2008; May 19, 2008; April 11, 2008; March 4, 2008; August 9, 2007; October 9, 2006; January 9, 2006, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity

Get the latest updates on ASHP's advocacy activity on drug shortages.



In Cooperation With

University of Utah & Novation
Advertisement